nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adjuvant CDK4/6 inhibitors combined with endocrine therapy in HR-positive, HER2-negative early breast cancer: A meta-analysis of randomized clinical trials
|
Gao, Hong-Fei |
|
|
59 |
C |
p. 165-175 |
artikel |
2 |
Adjuvant endocrine therapy for premenopausal women with breast cancer: Patient adherence and physician prescribing practices in Mexico
|
Villarreal-Garza, Cynthia |
|
|
59 |
C |
p. 8-15 |
artikel |
3 |
Adjuvant treatment for triple negative breast cancer with residual tumor after neo-adjuvant chemotherapy. A single institutional retrospective analysis
|
Bianco, Nadia |
|
|
59 |
C |
p. 351-357 |
artikel |
4 |
Anti-HER2 antibody prolongs overall survival disproportionally more than progression-free survival in HER2-Positive metastatic breast cancer patients
|
Chen, I-Chun |
|
|
59 |
C |
p. 211-220 |
artikel |
5 |
Anti-müllerian hormone levels and antral follicle count in women with a BRCA1 or BRCA2 germline pathogenic variant: A retrospective cohort study
|
Denis-Laroque, Laurie |
|
|
59 |
C |
p. 239-247 |
artikel |
6 |
A pilot study evaluating the effect of early physical therapy on pain and disabilities after breast cancer surgery: Prospective randomized control trail
|
Klein, Ifat |
|
|
59 |
C |
p. 286-293 |
artikel |
7 |
Aromatase inhibitors use and risk for cardiovascular disease in breast cancer patients: A population-based cohort study
|
Sund, Maria |
|
|
59 |
C |
p. 157-164 |
artikel |
8 |
Biological and clinical features of triple negative Invasive Lobular Carcinomas of the breast. Clinical outcome and actionable molecular alterations
|
Conforti, Fabio |
|
|
59 |
C |
p. 94-101 |
artikel |
9 |
Breast cancer screening using synthesized two-dimensional mammography: A systematic review and meta-analysis
|
Zeng, Baoqi |
|
|
59 |
C |
p. 270-278 |
artikel |
10 |
Breast cancer survivorship care during the COVID-19 pandemic within an urban New York Hospital System
|
Mo, Allen |
|
|
59 |
C |
p. 301-307 |
artikel |
11 |
Breast-related and body-related quality of life following autologous breast reconstruction is superior to implant-based breast reconstruction - A long-term follow-up study
|
Miseré, Renée ML. |
|
|
59 |
C |
p. 176-182 |
artikel |
12 |
Characteristics and outcomes of COVID-19 infection in 45 patients with breast cancer: A multi-center retrospective study in Hubei, China
|
Wei, Jielin |
|
|
59 |
C |
p. 102-109 |
artikel |
13 |
Clinicopathological response to neoadjuvant therapies and pathological complete response as a biomarker of survival in human epidermal growth factor receptor-2 enriched breast cancer – A retrospective cohort study
|
Davey, Matthew G. |
|
|
59 |
C |
p. 67-75 |
artikel |
14 |
Diagnosis, biology and epidemiology of oligometastatic breast cancer
|
Lacaze, Jean-Louis |
|
|
59 |
C |
p. 144-156 |
artikel |
15 |
Dissecting the biological heterogeneity of HER2-positive breast cancer
|
Schettini, Francesco |
|
|
59 |
C |
p. 339-350 |
artikel |
16 |
Editorial Board
|
|
|
|
59 |
C |
p. i |
artikel |
17 |
Efficacy and safety of palbociclib in patients with estrogen receptor–positive/human epidermal growth factor receptor 2–negative advanced breast cancer with preexisting conditions: A post hoc analysis of PALOMA-2
|
Gelmon, Karen |
|
|
59 |
C |
p. 321-326 |
artikel |
18 |
Evaluation of efficacy and safety of PARP inhibitors in breast cancer: A systematic review and meta-analysis
|
Chang, Xiao-Fei |
|
|
59 |
C |
p. 44-50 |
artikel |
19 |
Evolution of physical activity and body weight changes in breast cancer survivors five years after diagnosis – VICAN 2 & 5 French national surveys
|
Rey, Dominique |
|
|
59 |
C |
p. 248-255 |
artikel |
20 |
Feasibility and reliability of sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer patients with positive axillary nodes at initial diagnosis: An up-to-date meta-analysis of 3,578 patients
|
Cao, Siyang |
|
|
59 |
C |
p. 256-269 |
artikel |
21 |
Higher-risk breast cancer in women aged 80 and older: Exploring the effect of treatment on survival
|
Al-Rashdan, Abdulla |
|
|
59 |
C |
p. 203-210 |
artikel |
22 |
Internal mammary node irradiation in node-positive breast cancer treated with mastectomy and taxane-based chemotherapy
|
Cho, Won Kyung |
|
|
59 |
C |
p. 37-43 |
artikel |
23 |
Is the skin microbiota a modifiable risk factor for breast disease?: A systematic review
|
Wang, Katie |
|
|
59 |
C |
p. 279-285 |
artikel |
24 |
Long-term health-related quality of life of breast cancer survivors remains impaired compared to the age-matched general population especially in young women. Results from the prospective controlled BREX exercise study
|
Roine, Eija |
|
|
59 |
C |
p. 110-116 |
artikel |
25 |
Low neighborhood socioeconomic status is associated with higher mortality and increased surgery utilization among metastatic breast cancer patients
|
Bhattacharyya, Oindrila |
|
|
59 |
C |
p. 314-320 |
artikel |
26 |
Mammographic density and prognosis in primary breast cancer patients
|
Heindl, Felix |
|
|
59 |
C |
p. 51-57 |
artikel |
27 |
Patterns of care of breast cancer patients in Morocco – A study of variations in patient profile, tumour characteristics and standard of care over a decade
|
Mrabti, Hind |
|
|
59 |
C |
p. 193-202 |
artikel |
28 |
Population-based mammography screening attendance in Sweden 2017–2018: A cross-sectional register study to assess the impact of sociodemographic factors
|
Lagerlund, Magdalena |
|
|
59 |
C |
p. 16-26 |
artikel |
29 |
Population-based recurrence rates among older women with HR-positive, HER2-negative early breast cancer: Clinical risk factors, frailty status, and differences by race
|
Zhou, Jifang |
|
|
59 |
C |
p. 367-375 |
artikel |
30 |
Postmastectomy radiation therapy and survival outcome in older patients with T1-2N1 breast cancer
|
Luo, Chuanxu |
|
|
59 |
C |
p. 308-313 |
artikel |
31 |
Potential immune response to breast implants after immunization with COVID-19 vaccines
|
Weitgasser, Laurenz |
|
|
59 |
C |
p. 76-78 |
artikel |
32 |
Predicting the survival benefit of local surgery in patients aged 70 years or older with stage IV breast cancer: A population-based analysis
|
Chen, Yu-qiu |
|
|
59 |
C |
p. 124-134 |
artikel |
33 |
Quality indicators for breast cancer care: A systematic review
|
Maes-Carballo, Marta |
|
|
59 |
C |
p. 221-231 |
artikel |
34 |
Quality of life of therapies for hormone receptor positive advanced/metastatic breast cancer: Regulatory aspects and clinical impact in Europe
|
Moscetti, L. |
|
|
59 |
C |
p. 232-238 |
artikel |
35 |
Survival in breast cancer patients with a delayed DIEP flap breast reconstruction after adjustment for socioeconomic status and comorbidity
|
Coudé Adam, H. |
|
|
59 |
C |
p. 383-392 |
artikel |
36 |
Survival of south african women with breast cancer receiving anti-retroviral therapy for HIV
|
Phakathi, Boitumelo |
|
|
59 |
C |
p. 27-36 |
artikel |
37 |
Survival patterns of invasive lobular and invasive ductal breast cancer in a large population-based cohort with two decades of follow up
|
Chamalidou, C. |
|
|
59 |
C |
p. 294-300 |
artikel |
38 |
Ten years follow-up of histologically benign calcifications in the breast after vacuum-assisted stereotactic biopsy (VASB): Is additional mammographic follow-up warranted?
|
van Bekkum, Sara |
|
|
59 |
C |
p. 135-143 |
artikel |
39 |
The cost impact of unselective vs selective MammaPrint testing in early-stage breast cancer in Southern Africa
|
Myburgh, Ettienne J. |
|
|
59 |
C |
p. 87-93 |
artikel |
40 |
The usefulness of CanAssist breast in the assessment of recurrence risk in patients of ethnic Indian origin
|
Chandra Doval, Dinesh |
|
|
59 |
C |
p. 1-7 |
artikel |
41 |
The use of breast ultrasound for prediction of pathologic complete response in different subtypes of early breast cancer within the WSG-ADAPT subtrials
|
Graeser, Monika |
|
|
59 |
C |
p. 58-66 |
artikel |
42 |
Treatment of adenoid cystic carcinoma of the breast: Is postoperative radiation getting its due credit?
|
Gomez-Seoane, Andrew |
|
|
59 |
C |
p. 358-366 |
artikel |
43 |
Trends in endocrine therapy prescription and survival in patients with non-metastatic hormone receptor positive breast cancer treated with endocrine therapy: A population based-study
|
Mamguem Kamga, Ariane |
|
|
59 |
C |
p. 79-86 |
artikel |
44 |
Trends in incidence, treatment, survival and subsequent breast cancer in lobular carcinoma in situ in the Netherlands: A population-based analysis
|
van Maaren, Marissa C. |
|
|
59 |
C |
p. 376-382 |
artikel |
45 |
Triple-negative breast cancer outcomes: Does AJCC 8th staging improve chemotherapy decision-making
|
Lian, Chen-Lu |
|
|
59 |
C |
p. 117-123 |
artikel |
46 |
Tumour-infiltrating lymphocytes in non-invasive breast cancer: A systematic review and meta-analysis
|
Caparica, Rafael |
|
|
59 |
C |
p. 183-192 |
artikel |
47 |
Who are the women who enrolled in the POSITIVE trial: A global study to support young hormone receptor positive breast cancer survivors desiring pregnancy
|
Partridge, Ann H. |
|
|
59 |
C |
p. 327-338 |
artikel |